Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus.

Vaccine - 21 Apr 2009

Tiwari Mugdha, Parida Manmohan, Santhosh S R, Khan Mohsin, Dash Paban Kumar, Rao P V Lakshmana

Abstract excerpt

The recent resurgence of Chikungunya virus (CHIKV) in India and Indian Ocean Islands with unusual clinical severity is a matter of great public health concern. Despite the fact that CHIKV resurgence is associated with epidemic of unprecedented magnitude, no approved licensed vaccine is currently available. In the present study, a Vero cell adapted purified formalin inactivated prototype vaccine candidate was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Viral
Share to Chikungunya virus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Formaldehyde

Share to Neutralization Tests

Share to T-Lymphocytes, Cytotoxic

Share to Vaccines, Attenuated

Share to Vero Cells

Share to Viral Vaccines

Source

Identifiers

PMID: 19368794
DOI: 10.1016/j.vaccine.2009.02.062

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus.PMID 19368794Read ↗

The Safety and Efficacy of the Chikungunya Virus Vaccine: A Systematic Review and Meta Analysis.Semantic proximity Read ↗

Construction and immunogenicity of an mRNA vaccine against chikungunya virusSemantic proximity Read ↗

Evaluation of neutralizing antibodies produced by papaya mosaic virus nanoparticles fused to the E2EP3 peptide epitope of Chikungunya envelopeSemantic proximity Read ↗

Chikungunya virus vaccine: a decade of progress solving epidemiological dilemma, emerging concepts, and immunological interventionsSemantic proximity Read ↗

Antibody-based therapeutic interventions: possible strategy to counter chikungunya viral infection.Semantic proximity Read ↗

Expression and Characterization of Yeast Derived Chikungunya Virus Like Particles (CHIK-VLPs) and Its Evaluation as a Potential Vaccine CandidateSemantic proximity Read ↗

Safety and immunogenicity of a virus-like particle Chikungunya virus vaccineSemantic proximity Read ↗

Subunit vaccine formulations based on recombinant envelope proteins of Chikungunya virus elicit balanced Th1/Th2 response and virus-neutralizing antibodies in miceSemantic proximity Read ↗

Enhanced attenuation of chikungunya vaccines expressing antiviral cytokinesSemantic proximity Read ↗

Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL/6 mice.Semantic proximity Read ↗

Attenuated and vectored vaccines protect nonhuman primates against Chikungunya virusSemantic proximity Read ↗

Isolation and characterization of high affinity and highly stable anti-Chikungunya virus antibodies using ALTHEA Gold Libraries™Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.